CAS: 956590-23-1 - UNBS5162
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
UNBS-5162 REF: AN-AG01DX4WCAS: 956590-23-1 | 98% | 164,00 €~517,00 € | Vie 10 May 24 | |
UNBS5162 REF: TM-T2477CAS: 956590-23-1 | 99.97% | 43,00 €~1.291,00 € | Vie 17 May 24 | |
UNBS5162 REF: 3D-GNB59023CAS: 956590-23-1 | Min. 95% | A consultar | Vie 21 Jun 24 |
Ref: AN-AG01DX4W
10mg | 164,00 € | |
25mg | 233,00 € | |
50mg | 517,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Mayo de 2024
UNBS5162
CAS:956590-23-1
UNBS5162 (UNBS-5162) is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Fórmula:
C17H18N4O3
Pureza:
99.97%
Forma y color:
Solid
Peso molecular:
326.35
Ref: TM-T2477
1mg | 43,00 € | |
2mg | 54,00 € | |
5mg | 78,00 € | |
10mg | 130,00 € | |
25mg | 250,00 € | |
50mg | 417,00 € | |
100mg | 612,00 € | |
500mg | 1.291,00 € | |
1ml*10 (DMSO) | 128,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
UNBS5162
CAS:956590-23-1
UNBS5162 is a naphthalimide that has been shown to be dose-limiting in the treatment of …
Fórmula:
C17H18N4O3
Pureza:
Min. 95%
Peso molecular:
326.35 g/mol
Ref: 3D-GNB59023
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024